Search research articles
Contact Us
Filters
Showing results (651-660 of 791) with videos related to
Page
of 80
Sort By:
Cardiovascular Radiation Medicine
|
March 29, 2001
The American Brachytherapy Society perspective on intravascular brachytherapy
S Nag, P E Cole, I Crocker, et al.
The Journal of Infectious Diseases
|
October 10, 2022
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants
Frank P Esper, Thamali M Adhikari, Zheng Jin Tu, et al.
JAMA Network Open
|
April 26, 2021
Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity
Frank P Esper, Yu-Wei Cheng, Thamali M Adhikari, et al.
Histopathology
|
October 9, 2024
Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases
Rodrigo T Macedo, Vira Baranovska-Andrigo, Tamás Pancsa, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2013
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines
George D Demetri, Robert Benjamin, Charles D Blanke, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
August 31, 2006
Tissue response and Msx1 expression after human fetal digit tip amputation in vitro
Christopher H Allan, Philip Fleckman, Russell J Fernandes, et al.
The Journal of Pathology
|
May 28, 2005
The gene expression profile of extraskeletal myxoid chondrosarcoma
Subbaya Subramanian, Robert B West, Robert J Marinelli, et al.
The American Journal of Pathology
|
June 25, 2004
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status
Robert B West, Christopher L Corless, Xin Chen, et al.
Molecular Cancer Therapeutics
|
March 31, 2011
Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma
Jinu Abraham, Suresh I Prajapati, Koichi Nishijo, et al.
Cancer Letters
|
October 18, 2020
Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2
Wenxia Si, Bisheng Zhou, Wen Xie, et al.
Page
of 80
Search research articles
Search
Showing results (651-660 of 791) with videos related to
Sort By:
Page
of 80
Cardiovascular Radiation Medicine
|
March 29, 2001
The American Brachytherapy Society perspective on intravascular brachytherapy
S Nag, P E Cole, I Crocker, et al.
The Journal of Infectious Diseases
|
October 10, 2022
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants
Frank P Esper, Thamali M Adhikari, Zheng Jin Tu, et al.
JAMA Network Open
|
April 26, 2021
Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity
Frank P Esper, Yu-Wei Cheng, Thamali M Adhikari, et al.
Histopathology
|
October 9, 2024
Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases
Rodrigo T Macedo, Vira Baranovska-Andrigo, Tamás Pancsa, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2013
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines
George D Demetri, Robert Benjamin, Charles D Blanke, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
August 31, 2006
Tissue response and Msx1 expression after human fetal digit tip amputation in vitro
Christopher H Allan, Philip Fleckman, Russell J Fernandes, et al.
The Journal of Pathology
|
May 28, 2005
The gene expression profile of extraskeletal myxoid chondrosarcoma
Subbaya Subramanian, Robert B West, Robert J Marinelli, et al.
The American Journal of Pathology
|
June 25, 2004
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status
Robert B West, Christopher L Corless, Xin Chen, et al.
Molecular Cancer Therapeutics
|
March 31, 2011
Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma
Jinu Abraham, Suresh I Prajapati, Koichi Nishijo, et al.
Cancer Letters
|
October 18, 2020
Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2
Wenxia Si, Bisheng Zhou, Wen Xie, et al.
Page
of 80